Liver Lessons and Liquid Biopsies—Augusto Villanueva Rodriguez, MD—Icahn School of Medicine at Mount Sinai
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 23 June 2020
⏱️ 33 minutes
🧾️ Download transcript
Summary
Assistant Professor at Icahn School of Medicine at Mount Sinai, Dr. Augusto Rodriguez, talks about the scope of his work and research on different aspects of liver oncology.
In this episode, you will learn:
- Which underlying diseases are the main causes of liver cancer, and how long it generally takes for liver cancer to develop
- How many therapies have been approved for use in patients with liver cancer, and why it has been challenging to determine which type of therapy will work best for a particular patient
- What it means for a liver tumor to be heterogenous and why it's significant
Dr. Rodriguez's work centers around the goal of incorporating molecular information from tumors into tools that can be applied in the clinical setting to improve prognosis predictions, and developing novel methods for early detection of liver cancer.
The current gold standard for early detection of liver cancer is a combination of abdominal ultrasonography to look for evidence of small tumor formation, and blood tests to identify the levels of a certain protein known to be elevated in patients with liver cancer.
So, what's wrong with the current gold standard? Dr. Rodriguez explains that in addition to operator error with regard to the ultrasound procedure, it requires patients to travel to an imaging center every six months, which is difficult to manage for many people. Due to the inconvenience and difficulty presented by compliance with the gold standard protocol, many people end up developing liver cancer that goes undetected for far too long.
A potential solution that Dr. Rodriguez has his eyes on is a technology called liquid biopsy. In essence, it entails an analysis of tumor components within the bloodstream, such as fragments of DNA from tumors or extracellular vesicles released from tumors. The detection of such components in a blood sample taken at the point of care can detect liver tumors when they are very small, leading to better overall prognosis.
In addition, liquid biopsy may address another complication in the area of liver cancer treatment, which is the determination of how best to sequence the many therapies that have become available in recent years.
Dr. Rodriguez discusses a number of fascinating topics. Tune in for all the details.
Available on Apple Podcasts: apple.co/2Os0myK
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Forget frequently asked questions. |
| 0:02.0 | Common sense, common knowledge, or Google. |
| 0:05.0 | How about advice from a real genius? |
| 0:07.0 | 95% of people in any profession are good enough to be qualified and licensed. |
| 0:11.0 | 5% go above and beyond. They become very good at what they do, but only 0.1% are real Jesus. |
| 0:18.0 | Richard Jacobs has made it his life's mission to find them for you. He hunts down and interviews geniuses in every field, sleep science, |
| 0:25.7 | cancer, stem cells, ketogenic diets, and more. Here come the geniuses. This is the Finding Genius |
| 0:32.1 | podcast that Richard Jacobs. This is the Finding Genius Podcast. |
| 0:33.0 | That is Richard Jacobs. |
| 0:35.0 | Hello, this is Richard Jacobs with the Finding Genius Podcast. |
| 0:41.0 | I have Augusto Villeneva Rodriguez. He's an assistant professor at the ICON School of Medicine at Mount Sinai and he works on liver related issues, diseases. He's a hematologist, and he also deals with oncology, you know, liver cancer type issues. |
| 0:56.5 | So, so thanks for coming. |
| 0:58.3 | Thanks for having me. |
| 1:00.3 | Yeah, what's your, you know, in a bit more detail, what's your research about, what's your work about? |
| 1:05.6 | Yeah, so I work in different aspects related to liver cancer and I would say the general scope of my work is trying to incorporate molecular information |
| 1:17.7 | from the tumor in tools that can be applied in the clinical setting to improve prognosis prediction, |
| 1:25.0 | prediction of response to different therapies, |
| 1:27.0 | or most recently have been very interesting |
| 1:29.0 | trying to develop novel methods for early detection of liver cancer. |
| 1:34.0 | With liver cancer, who does it strike? |
| 1:38.0 | Is it older people? |
| 1:39.0 | Is it people that drink a lot of alcohol? |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.